About
Mark Brown is a Partner at King & Spalding, nationally recognized in FDA regulatory matters, civil litigation, criminal investigations, compliance, and risk assessments. He advises pharmaceutical, medical device, and biotech companies, as well as pharmacies, on FDA requirements and issues arising in products liability litigation. A former Associate Chief Counsel for FDA, he is Chair of the FDA and Life Sciences practice. He has a national reputation for resolving complex FDA compliance and enforcement matters, including consent decrees and injunction defense.
Practice areas
FDA RegulatoryCivil LitigationCriminal InvestigationsComplianceRisk AssessmentsProducts Liability
Office
Expertise
Food & Drug Administration (FDA) regulatory mattersCivil litigationCriminal investigations and prosecutionsCompliance mattersRisk assessmentsProducts liability litigationConsent decreesInjunction actions